Skip to main content
Premium Trial:

Request an Annual Quote

GeneGo, GenomeQuest Integrate Next-Gen Data Tools

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GeneGo today said it has integrated its MetaCore and MetaDrug products with GenomeQuest's Sequence Data Management platform.

As a result, scientists with particular genes of interest will be able to pass their gene lists with their associated expression values to GeneGo's pathway analysis software tools.

Being able to analyze large numbers of datasets, as millions of reads are reduced to manageable lists of genes of interest, and being able to visualize the location of those genes in specific pathways are a "significant accomplishment" in integrating 'omics software offerings, Don Gregory, GenomeQuest's director of field application scientists, said in a statement.

"Scientists will be able to quickly focus on their scientific questions, rather than manipulating large reads datasets and lists of thousands of genes," he said.

Julie Bryant, vice president of business development at GeneGo, which announced a next-gen sequencing integration deal with Omicsoft a week ago, added that the integration of the two firms' platforms will allow joint customers to seamlessly work with next-generation sequencing data in the context of pathways. "The integrated workflows will lead our users from raw sequence runs to functional hypothesis generation of drug targets and biomarkers," she said.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.